PARP inhibitor olaparib sensitizes esophageal carcinoma cells to fractionated proton irradiation

Proton beam therapy (PBT) combined with chemotherapy, such as cis-diamminedichloroplatinum (II) (CDDP) and 5-fluorouracil (5-FU), has been employed as an alternative approach to improve clinical outcomes. PBT has been reported to be effective against esophageal cancer. However, apart from 5-FU and C...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Radiat Res
Egile Nagusiak: Kageyama, Shun-ichiro, Junyan, Du, Hojo, Hidehiro, Motegi, Atsushi, Nakamura, Masaki, Tsuchihara, Katsuya, Akimoto, Tetsuo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Regular Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7246074/
https://ncbi.nlm.nih.gov/pubmed/31976528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jrr/rrz088
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak